-
-
-
-
-
-
-
BrainStorm Cell Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Brainstorm Cell Therapeutics (BCLI) Misses Q3 EPS by 176c
-
-
-
-
-
-
-
Brainstorm Cell Therapeutics (BCLI) Misses Q3 EPS by 14c
-
-
-
-
-
-
-
BrainStorm Cell Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
BrainStorm Cell Therapeutics Receives Refusal to File Letter from FDA for its New Biologics License Application for NurOwn for the treatment of ALS
-
-
-
-
-
-
-
BrainStorm to Announce First Quarter 2022 Financial Results and Provide a Corporate Update
-
-
-
-
-
-
-
BrainStorm Announces Second Quarter 2021 Financial Results and Provides a Corporate Update
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

